High-dose 13.3 mg/24 h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use

Journal article

Peer reviewed

J.L. Molinuevo, J. Cummings, L. Frölich, J. Galvin, T. Krahnke and C. Strohmaier

Journal of the neurological sciences, Vol.333, pp.e348-e348

2013-10-15

Metrics

8 Record Views

Title: High-dose 13.3 mg/24 h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use
Creators: J.L. Molinuevo - Alzheimer'/INS;s Disease and Other Cognitive Disorders Unit, Neurology Service, ICN Hospital Clinic i Universitari, Barcelona, Spain
J. Cummings - Lou Ruvo Brain Institute
L. Frölich - Central Institute of Mental Health
J. Galvin - New York University Langone Medical Center
T. Krahnke - Novartis
C. Strohmaier - Novartis
Publication Details: Journal of the neurological sciences, Vol.333, pp.e348-e348
Publisher: Elsevier B.V
Academic Unit: Miller School of Medicine; UMMG Department of Neurology
Language: English
Resource Type: Journal article
Record Identifier: 991031739784802976